| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(58)92004-X |
| P698 | PubMed publication ID | 13540244 |
| P2093 | author name string | K LUNDBAEK | |
| O J RAFAELSEN | |||
| K NIELSEN | |||
| P2860 | cites work | A new blood-sugar reducing substance; preliminary data. | Q30832044 |
| [A new anti-diabetes principle; results of clinical research] | Q73821639 | ||
| [An effective peroral anti-diabetic drug (BZ 55)] | Q73821642 | ||
| Orinase, a new oral hypoglycemic compound | Q73990204 | ||
| In vitro studies on the action of sulfonamide hypoglycemic agents | Q74050417 | ||
| [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies] | Q74082834 | ||
| Action of butyltolylsulfonylurea on liver glycogenolysis | Q74181038 | ||
| Hypoglycemic action of orinase, effect on output of glucose by liver | Q74181064 | ||
| Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action | Q74248083 | ||
| Lack of effect of carbutamide on activity of rat liver glucose-6-phosphatase | Q74311517 | ||
| Insulin secretion following carbutamide injections in normal dogs | Q74349558 | ||
| Some effects of BZ-55 (carbutamide) in experimental animals | Q74386870 | ||
| Studies of the effect of carbutamide on glucose-6-phosphatase | Q74386876 | ||
| Compounds inhibiting insulin degradation | Q74386883 | ||
| Effects of substituted sulfonylureas on rat diaphragm and liver tissue | Q74386886 | ||
| Observations on the action of tolbutamide | Q74386900 | ||
| Studies of the mechanism of action of sulfonylurea derivatives | Q74386921 | ||
| The effect of sulfonylureas on the rates of metabolic degradation of insulin-I131 and glucagon-I131 in vivo and in vitro | Q74386925 | ||
| Action of the hypoglycemic sulfonyl compounds in hypophysectomized, adrenalectomized, and depancreatized animals | Q74598851 | ||
| The role of insulin in the action of the hypoglycemic sulfonyl compounds | Q74598855 | ||
| The effect of tolbutamide on insulin-I131 degradation in the extrahepatic tissues | Q74598857 | ||
| Studies on the mechanism of tolbutamide hypoglycemia in animal and human subjects | Q74598868 | ||
| A concept of the mechanism of sulfonylurea-induced hypoglycemia based on studies of glucose and pentose disposition in man | Q74598871 | ||
| The role of insulinase in the hypoglycemic response to sulfonylureas | Q74598874 | ||
| Perfusion studies with sulfonylureas in dogs | Q74598880 | ||
| Studies on the disposition of isotopic glucose in vivo and in vitro under the influence of sulfonylureas | Q74598882 | ||
| Functional and histological studies concerning the action of sulfonylureas | Q74598884 | ||
| Long-term studies of the sulfonylureas in totally depancreatized dogs | Q74598894 | ||
| Studies concerning the role of the liver in the hypoglycemic response of animals to tolbutamide | Q74598897 | ||
| A comparative study of the action of three hypoglycemic compounds on the blood sugar and the islet cells of the pancreas in the rat | Q74802179 | ||
| Effect of oral antidiabetic drugs on blood-sugar and inorganic phosphate curves in oral and intravenous glucosetolerance tests | Q74802570 | ||
| P433 | issue | 7029 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1036-1038 | |
| P577 | publication date | 1958-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Mode of action of oral antidiabetic compounds | |
| P478 | volume | 1 |
| Q40039662 | A Survey of Diabetes Mellitus |
| Q55483129 | Long-term results in treatment of diabetes mellitus with the sulphonylureas. |
| Q36819966 | Oral hypoglycaemic drugs |
| Q77195362 | Oral treatment of diabetes; trail of phenethyldiguanide (D.B.I.). |
| Q42950003 | The effect of insulin antibodies on glucose uptake by the isolated rat diaphragm |
| Q51316563 | The mode of action of oral antidiabetic compounds. |
Search more.